Germany · Product · Checked
Section 4b Arzneimittelgesetz (German Medicines Act), non-routinely produced advanced therapy medicinal products
Names the Paul-Ehrlich-Institut as the authority that authorises non-routinely manufactured advanced therapy medicinal products under section 4b (3) of the German Medicines Act.
Primary source
Paul-Ehrlich-Institut: the instrument text. Language of the text: English.
Verification record
4 checked · 0 company says · 0 reported · 0 not found · 0 not yet checked
- Instrument Section 4b Arzneimittelgesetz (German Medicines Act), non-routinely produced advanced therapy medicinal products (Section 4b (3) AMG) Checked Source pei.de Instrument title and number as printed on the primary text read. Checked
- Regulator Paul-Ehrlich-Institut Checked Source pei.de Issuing body as printed on the primary text read. Checked
- Effective date Standing: The page states no effective date; it carries an update date of 26.11.2019. Checked Source pei.de Date or standing status as read on the primary text. Checked
- What it requires Names the Paul-Ehrlich-Institut as the authority that authorises non-routinely manufactured advanced therapy medicinal products under section 4b (3) of the German Medicines Act. Checked Source pei.de Written from what the primary text states. Checked
Check history: Section 4b Arzneimittelgesetz (German Medicines Act), non-routinely produced advanced therapy medicinal products was last read in its primary source on November 14, 2026. No earlier checks are recorded. How records are checked.
Corrections: none recorded for this instrument. To ask for one, write to [email protected] with the instrument's name; every correction is checked against the primary text before the record changes.
At a glance
- Regulator: Paul-Ehrlich-Institut
- Number: Section 4b (3) AMG
- Governs: Product
- Effective: Standing: The page states no effective date; it carries an update date of 26.11.2019.
- Status: Checked
Country page